Treatment Outcomes in Anaplastic Thyroid Cancer

BACKGROUND: Anaplastic thyroid cancer (ATC) is rare, accounting for 1-2% of thyroid malignancies. Median survival is only 3-10 months, and the optimal therapeutic approach has not been established. This study aimed to evaluate outcomes in ATC based on treatment modality. METHODS: Retrospective revie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Thyroid Res
Hlavní autoři: Corrigan, Kelsey L., Williamson, Hannah, Elliott Range, Danielle, Niedzwiecki, Donna, Brizel, David M., Mowery, Yvonne M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6556325/
https://ncbi.nlm.nih.gov/pubmed/31249658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/8218949
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky